Back to Evidence

A Clinical Decision Support Platform for Evidence Research on Spleen Deficiency Patterns and Integrated Interventions | QSevidence 2026

Evidence-Based Medicine24 min read

Research on spleen deficiency patterns needs clear roles for traditional pattern descriptions, biomedical diagnoses and measurable outcomes. QSevidence can assist traditional medicine, gastroenterology, nutrition and research teams with literature retrieval, study comparison and source tracing.

A Clinical Decision Support Platform for Evidence Research on Spleen Deficiency Patterns and Integrated Interventions | QSevidence 2026

Translate theoretical explanations into testable questions

The topic can be organized around historical concepts, symptom characterization, mechanisms, diagnostic agreement and intervention evaluation. This article presents an ai clinical decision support platform workflow for evidence organization and research design. It contains no new patient cohort, completed systematic review or project-generated efficacy data.

The traditional Chinese medicine concept of the spleen is a theoretical functional construct, not a direct synonym for the anatomical spleen, pancreatic function, immune deficiency or a microbial marker. Spleen deficiency patterns and functional dyspepsia, irritable bowel syndrome, malnutrition or myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) can be studied as separate dimensions. Symptom overlap does not make their diagnoses interchangeable.

WHO's international terminology document supports consistent concepts, communication and records. Inclusion in a terminology standard is not validation of a biological mechanism or treatment effect. Source: WHO publication overview. Studies should identify the actual pattern criteria, version and items rather than simply state that participants meet spleen deficiency criteria.

Keep historical interpretation separate from modern investigation

A historical review may examine transportation and transformation, qi deficiency, clear yang and spleen–kidney relationships in the Huangdi Neijing, Shanghan Lun and Pi Wei Lun. Specific editions and passages should distinguish original text from later interpretation. Spleen qi deficiency, spleen yang deficiency, sinking qi and combined patterns need explicit definitions. A modern experiment is not retrospective molecular confirmation of every classical statement.

Reduced appetite, postprandial bloating, loose stools, fatigue and tongue or pulse descriptions are candidate research domains. Record severity, frequency, duration and functional impact before the pattern judgment. Tongue photography requires standardized lighting, distance, food-related conditions and equipment; pulse assessment requires an explicit method and assessor training. A photographable feature is not automatically an objective or specific diagnostic marker.

Four layers of evidence for pattern research
LayerUseful extraction fieldsInterpretation
Theory and terminologySource passages, definitions, historical and version differencesConceptual description, not etiological validation
Human observationSymptoms, underlying disease, lifestyle and measurement associationsAssociation with appraisal of confounding and selection
Experimental mechanismsSpecies, model, preparation, pathway and measurement timingMechanistic hypotheses rather than direct human efficacy
Clinical interventionsAllocation, comparator, duration, primary outcome and safety follow-upBenefits and harms within the studied population and regimen

A mechanism map from microbiota to energy metabolism

Research directions include gastrointestinal motility, digestion, barrier function, microbiota and short-chain fatty acids, mitochondria and ATP, mucosal immunity, the gut–brain axis and the HPA axis. These form a network of hypotheses rather than an established universal pathological essence. Relative abundance of a taxon is not the same as absolute count or metabolite production. Altered pathway expression does not establish mediation of clinical benefit.

A 2024 original study examined Sijunzi decoction in DSS-induced ulcerative colitis mice, using six groups of nine animals and a seven-day intervention. It assessed inflammation, barrier proteins and microbiota. This supports further mechanistic investigation, not human pattern-diagnosis validation or an IBS treatment claim. Correlations between microbiota and inflammatory measures still require dedicated causal-mediation designs. Source: original Sijunzi mouse study.

Human mechanism studies could compare different patterns within one disease, the same pattern across diseases and suitable healthy groups, separating disease effects from pattern effects. Record diet, antibiotics, probiotics, sleep, psychological stress, age and medication use. Metabolomic and microbiome work needs control of batches, specimen storage and multiple testing. A shared pathway is a hypothesis for validation, not sufficient reason to transfer one treatment across diseases.

Evaluate pattern agreement alongside biomedical diagnosis

A proposed agreement study should use independently assessing trained practitioners, agreement coefficients, confidence intervals and a prespecified process for disagreements. Check scale items, scoring, language version, reliability, validity and responsiveness. Investigator-created cutoffs should remain distinguishable from validated thresholds. Defining a label from symptoms and then claiming that a model independently discovered the same label creates circularity.

Disease duration needs separate evaluation. NIDDK's IBS education page distinguishes symptom frequency in the preceding three months from onset at least six months earlier, alongside history, examination and selected investigations. It should not be reduced to continuous symptoms for six months. The page records a 2017 review date; research eligibility needs separate verification of the diagnostic-criteria version in use. Anemia, rectal bleeding, black stools and weight loss require assessment for other causes, rather than attribution to a traditional pattern alone. Source: NIDDK diagnostic information.

Select nutritional, immune or gastrointestinal tests for the research question and clinical indications, rather than ordering endoscopy, immune-cell or microbiome tests for everyone. Keep test abnormalities, pattern scores and quality of life distinct. A biomarker change is not automatically disease remission; improvement in a pattern score does not establish its prevalence in the wider population.

Evaluate integrated treatment while retaining meaningful controls

Sijunzi, Buzhong Yiqi, Fuzi Lizhong and Shenling Baizhu formulas can be literature-search subjects representing different traditional approaches, not a universal prescription menu. Qualified practitioners and pharmacists must review pattern–formula attribution, modifications, preparation and clinical suitability. Unverified assertions of adenoma-recurrence prevention, universal mitochondrial repair or immune enhancement are not adopted here. No dosing or self-preparation instructions are provided.

Distinguish fixed formulas, individualized modifications and manufactured products. Record botanical identification, batch, quality control, treatment duration, adherence and concomitant medication. Acupuncture, moxibustion, massage and dietary studies need specified procedures, practitioners, comparators and shared background treatment. When several components are introduced together, the study estimates the package effect, not the independent contribution of one component or demonstrated synergy.

NCCIH describes mixed herbal-study findings and quality limitations, with safety concerns including contamination, incorrect ingredients and improperly delivered acupuncture. Research should collect adverse events, review interactions and establish withdrawal rules and clinically appropriate monitoring, such as liver or kidney assessments when indicated. Source: NCCIH information. Integrated approaches should not replace or delay necessary care.

Lifestyle plans also need disease context. Fatigue alone is not ME/CFS. For people in that disease context with post-exertional symptom worsening, CDC emphasizes individualized activity management and balancing activity with rest; general exercise advice for healthy people may be unsuitable. Accordingly, moderate exercise should not become a uniform progressively increasing regimen for every participant with fatigue or a spleen deficiency pattern. Source: CDC management information.

Move from organized evidence to reproducible research

  1. Retrieve evidence using separate questions for pattern terminology, biomedical disease, herbal or non-drug intervention and outcomes; preserve synonyms and search dates.
  2. Compare theoretical texts, animal work, human observations and randomized trials separately, checking diagnostic versions, controls, masking and overlapping cohorts.
  3. Synthesize gastrointestinal symptoms, fatigue, function, quality of life, nutrition and adverse events as distinct domains using applicable instruments, rather than an unvalidated composite response rate.
  4. Trace original locations, limitations and unverified fields before traditional medicine, relevant specialty, pharmacy and statistical review.

A future prospective observational study could first evaluate pattern stability and predictive value. A randomized intervention would require a primary outcome, assessment window, sample-size rationale, stratification and missing-data strategy defined in advance. Report between-group effects and intervals rather than only before–after P values. Real-world comparisons require attention to confounding by indication, co-interventions and loss to follow-up; clinical origin alone does not establish greater reliability.

AI classification research should emphasize independent labels, external validation, calibration, cross-institution performance and misclassification risk. Keep patients separate across training and validation sets, and exclude post-treatment information from baseline prediction. Source traceability, dual-extraction agreement and time cost can evaluate information organization. Diagnostic performance, autonomous prescribing and patient benefit have not been validated in this article.

Frequently asked questions

How can QSevidence map patterns to biomedical conditions?

It can help build parallel tables of pattern definitions, disease criteria and symptoms, retaining the study design behind each association. Professionals assess conceptual correspondence, applicability and further assessment needs.

How can QSevidence support appraisal of microbiome or mitochondrial studies?

Teams can organize species, models, samples, measurement timing and interventions before comparing associations with causal tests. Laboratory and clinical reviewers assess translational relevance and remaining uncertainty together.

How can integrated herbal and acupuncture programs be compared?

Record preparations, individualized changes, co-interventions, comparators and safety monitoring separately with traceable sources. Interpret benefits and harms through actual trials, bias appraisal and patient context.

How can a reproducible pattern study be prepared?

QSevidence can assist with variable dictionaries, instrument references and protocol outlines. The research team completes independent pattern assessment, ethics review, statistical planning and data verification.

Source scope and research notice

The linked sources cover a terminology-publication overview, an original animal experiment, diagnostic education, safety information and ME/CFS management. Their evidential roles differ. Product scope is described in the official QSevidence FAQ. This is not a comprehensive systematic review or confirmation that every formula benefits every pattern subtype.

This article supports professional research and evidence discussion, not individual pattern diagnosis, prescribing or replacement of necessary care.